NCT05276401 - Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 11, 2022

Primary Completion Date

May 18, 2022

Study Completion Date

June 15, 2022

Conditions

Chronic Diabetic Foot Ulcers

Interventions

DRUG

5% Bisphosphocin Topical Gel

Topical Gel

DRUG

Placebo Topical Gel

Topical Gel

DRUG

10% Bisphosphocin Topical Gel

Topical Gel

Trial Locations (5)

ACM Global Laboratories, Rochester

Doctors Research Network, South Miami

NEA Baptist Clinic, Jonesboro

Futuro Clinical Trials, LLC, McAllen

Limb Preservation Platform, Inc., Fresno